Ferric Carboxymaltose Injection [Ferinject]

DRUG2 trials

Sponsors

Sichuan Huiyu Pharmaceutical Co., Ltd, Fundación para la Investigación del Hospital Clínico de Valencia

Conditions

Acute Coronary Syndromes (ACS)AnaemiaElderly (People Aged 65 or More)Iron DeficienciesIron Deficiency

Phase 1

Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia

CompletedNCT06080555

Sichuan Huiyu Pharmaceutical Co., LtdAnaemia, Iron Deficiency

Start: 2023-10-09End: 2024-03-22Updated: 2024-04-18

Phase 4

Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome

RecruitingNCT07476859

Fundación para la Investigación del Hospital Clínico de ValenciaAcute Coronary Syndromes (ACS), Elderly (People Aged 65 or More), Iron Deficiencies

Start: 2026-03-05End: 2028-05-01Target: 538Updated: 2026-03-24